SS Innovations Wins Outstanding Company at 2026 Surgical Robotics Industry Awards

SS Innovations International Inc. (NASDAQ: SSII) received the Outstanding Company award at the 2026 Surgical Robotics Industry Awards, highlighting its commercial growth and global expansion of the SSi Mantra surgical robotic system.

Chicago Metrowire Staff
Healthcare
SS Innovations Wins Outstanding Company at 2026 Surgical Robotics Industry Awards

SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA). The award, presented by the industry organization, recognizes the company's work in developing and commercializing robotic surgery technology (https://nnw.fm/mXdgs).

The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties. SS Innovations was selected from a field of ten finalists that included established names such as Intuitive, Johnson & Johnson MedTech, Medtronic, Distalmotion, FUTEK, Meril, MicroPort, Precision IO Group, and THINK Surgical. The award criteria encompass commercial performance, technological innovation, societal impact, customer recognition, ethical standards, and workplace practices.

Chairman and Chief Executive Officer Dr. Sudhir Srivastava stated that the award reflects the company's focus on expanding access to robotic surgery while developing technologies intended to improve affordability for hospitals and healthcare systems. The recognition coincides with continued operational growth for the SSi Mantra surgical robotic platform. As of June 22, 2026, surgeons had completed a cumulative 11,719 multi-specialty procedures using the system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. Physicians have used the platform in more than 170 different types of surgical procedures.

Training has also expanded alongside system adoption, with approximately 2,100 physicians completing training on the SSi Mantra platform. This is an important consideration for robotic surgery systems, as physician education and clinical familiarity often influence hospital purchasing decisions and long-term utilization. The company's commercial footprint has broadened internationally, with regulatory approvals granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates.

SS Innovations describes the SSi Mantra as a modular, multi-arm robotic surgery platform designed to support multiple surgical specialties. The system incorporates between three and five robotic arms, a three-dimensional 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities. Its instrument portfolio includes more than 40 robotic surgical instruments, including smaller 5-millimeter instruments intended for pediatric and ear, nose, and throat procedures. The company has also developed a portable tele-surgeon console, the SSi MantrAsana, which supports remote surgical capabilities.

For more information, visit the company's website at www.SSInnovations.com. NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company's newsroom at https://nnw.fm/SSII.

Blockchain Registration

QR Code for Blockchain Registration